STAGEONE PLUS Trademark

Trademark Overview


On Tuesday, July 22, 2025, a trademark application was filed for STAGEONE PLUS with the United States Patent and Trademark Office. The USPTO has given the STAGEONE PLUS trademark a serial number of 99296669. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, December 10, 2025. This trademark is owned by Calviri, Inc.. The STAGEONE PLUS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Blood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories
stageone plus

General Information


Serial Number99296669
Word MarkSTAGEONE PLUS
Filing DateTuesday, July 22, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, December 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBlood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories
Pseudo MarkSTAGE ONE PLUS

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 22, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCalviri, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhoenix, AZ 85004

Trademark Events


Event DateEvent Description
Tuesday, July 22, 2025NEW APPLICATION ENTERED
Tuesday, July 22, 2025APPLICATION FILING RECEIPT MAILED
Monday, December 1, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 9, 2025ASSIGNED TO EXAMINER
Wednesday, December 10, 2025NON-FINAL ACTION WRITTEN
Wednesday, December 10, 2025NON-FINAL ACTION E-MAILED
Wednesday, December 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED